Kamada Ltd. (NASDAQ: KMDA)
$5.80
-0.0200 ( -0.34% ) 21.8K
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
Market Data
Open
$5.80
Previous close
$5.82
Volume
21.8K
Market cap
$333.38M
Day range
$5.72 - $5.82
52 week range
$4.08 - $6.53
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 2 | Nov 08, 2023 |
6-k | Quarterly Reports | 2 | Oct 16, 2023 |
6-k | Quarterly Reports | 2 | Oct 10, 2023 |
6-k | Quarterly Reports | 2 | Aug 30, 2023 |
6-k | Quarterly Reports | 45 | Aug 16, 2023 |
6-k | Quarterly Reports | 2 | Aug 09, 2023 |
6-k | Quarterly Reports | 3 | Jul 13, 2023 |
6-k | Quarterly Reports | 2 | Jul 12, 2023 |